EVE Health GroupASX:EVE -2.44% Median PS Value is A$0.00 as of Jun. 27, 2026. The stock has 5 warning signs investors should review. Among 1,139 Consumer Packaged Goods companies, EVE Health Group ranks worse than 87796.22% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for EVE Health Group's Median PS Value or its related term are showing as below:
ASX:EVE's Price-to-Median-PS-Value is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.83 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
EVE Health Group (ASX:EVE) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
EVE Health Group's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.02
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVE Health Group Median PS Value Related Terms
EVE Health Group Median PS Value Historical Data
* Premium members only.
The historical data trend for EVE Health Group's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, EVE Health Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group Price-to-Median-PS-Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where EVE Health Group's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EVE Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVE Health Group (ASX:EVE) has a Median PS Value of A$0.00 as of Jun. 27, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #999999 out of 1139 companies in the Consumer Packaged Goods industry.
Is EVE Health Group's Median PS Value too high?
EVE Health Group's current Median PS Value is A$0.00. Based on the distribution chart, EVE Health Group ranks #999999 out of 1139 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does EVE Health Group's Median PS Value compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #999999 out of 1139 companies for Median PS Value. This places EVE Health Group in the lower half of its industry. The industry median Median PS Value is 0.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Consumer Packaged Goods company?
The median Median PS Value among Consumer Packaged Goods companies is 0.83, based on 1,139 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median Median PS Value is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current Median PS Value is A$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 100% above its estimated fair value. The current Median PS Value is A$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current Median PS Value is A$0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 